Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children

NCT04569357 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

363

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Prospekta
DRUG: Placebo

Sponsor

Materia Medica Holding